New Iridium Scores $18M Series B, Paving the Way for a Low-Carbon Chemical Revolution

New Iridium, a pioneering sustainable chemical innovation company based in Colorado, is thrilled to announce that it has secured $18,000,000 in new funding. This milestone investment will accelerate the development and commercialization of its groundbreaking, low-carbon chemical manufacturing platform. By integrating thermal and photocatalytic technologies with bio-based feedstocks and captured CO₂, New Iridium is poised to revolutionize chemical production by converting renewable inputs into high-value chemicals such as bio-based acetic acid and ethyl acetate. These products serve as drop-in replacements for traditional fossil-derived chemicals, thereby offering a scalable pathway towards decarbonizing critical chemical industry segments without sacrificing performance or supply chain reliability. The new funding injection will support the company’s efforts to further advance its flagship products—bio-based acetic acid, ethyl acetate, and related acetate esters—which play key roles across diverse applications from consumer goods and personal care products to industrial adhesives and coatings. In addition, the capital will help accelerate the development of CO₂-derived building block chemicals, including acrylic acid and methacrylic acid, enhancing New Iridium’s pipeline and reinforcing its position at the forefront of sustainable chemical production. A significant advantage of New Iridium’s approach is its modular and distributed manufacturing model, designed to align with regional feedstock availability and renewable energy infrastructure. This strategy not only supports localized resilient supply chains but also integrates seamlessly with the existing U.S. bioethanol infrastructure, leveraging domestically sourced feedstocks. With this fresh capital, New Iridium is primed to drive forward its mission of reducing the carbon footprint of the chemical industry while ensuring competitive performance and sustainable growth.